Arrowhead Pharmaceuticals, Inc.· ARWR

🇺🇸 US · MidSP400NASDAQ

Healthcare Biotechnology Website

Price: $66.48
Day: -1.86%
Mkt Cap: $9.36B
52W Range: $30.71 – $95.49
Volume: 4.02M
Beta: 1.28

D25D FrameworkTTM Data

Peer Comparison

Performance vs sector and industry peers across 40 metrics.

Peer Comparison: 2.4 / 5 (Weak) against 136 sector peers in United States · Mid Cap · Healthcare
Pillars: strongest Top Line Growth 4.5, weakest Margin Efficiency 1.0 (9 of 10 ranked)
Ranks: ROIC 31st percentile, operating margin 10th percentile

Blog

stockoscope.com

Arrowhead Pharmaceuticals, Inc.

ARWR|Healthcare|Biotechnology

Comparing against 136 sector peers in United States · Mid Cap · Healthcare

Peer Comparison

Dimension 2 of 5

Revenue Growth

52%ile

16.9%

Operating Margin

10%ile

-33.8%

ROIC

31%ile

-12.1%

FCF Yield

49%ile

-0.8%

Growth & Cash Flow Quality

Percentile ranking across profitability growth and cash generation

EBITDA Growth

167.3%

EBIT Growth

112.4%

Net Income Growth

115.6%

OCF Growth

-370.3%

FCF Growth

326.3%

Income Quality

0.22

Returns on Capital (TTM)

ROE(-60.5%)

12%ile

Bottom 20%

PoorWeakAdequateStrongExceptional

ROCE(-12.4%)

30%ile

Below Avg

PoorWeakAdequateStrongExceptional

ROA(-15.2%)

28%ile

Below Avg

PoorWeakAdequateStrongExceptional

ROIC(-12.1%)

31%ile

Below Avg

PoorWeakAdequateStrongExceptional

Profit Margins (TTM)

Gross Margin(N/A)

N/A

PoorWeakAdequateStrongExceptional

EBITDA Margin(-21.0%)

11%ile

Bottom 20%

PoorWeakAdequateStrongExceptional

Operating Margin(-33.8%)

10%ile

Bottom 20%

PoorWeakAdequateStrongExceptional

Net Margin(-47.8%)

11%ile

Bottom 20%

PoorWeakAdequateStrongExceptional

Leverage & Coverage (TTM)

Debt/Equity

17%ile

1.86

Debt/Capital

16%ile

0.65

Net Debt/EBITDA

8%ile

-5.77

Interest Coverage

21%ile

-2.45x

Liquidity (TTM)

Current Ratio

59%ile

5.90

Quick Ratio

61%ile

5.90

Cash Ratio

7%ile

0.19

WC Turnover

42%ile

0.46

Operational Efficiency (TTM)

Asset Turnover

31%ile

0.32

DSO

73%ile

4.66

Days Inventory

77%ile

0.00

Cash Conv. Cycle

72%ile

4.66

TTM: Trailing Twelve Months · EBITDA: Earnings Before Interest, Taxes, Depreciation & Amortization · EBIT: Earnings Before Interest & Taxes · ROA: Return on Assets · ROIC: Return on Invested Capital · ROCE: Return on Capital Employed · ROE: Return on Equity · OCF: Operating Cash Flow · FCF: Free Cash Flow · DSO: Days Sales Outstanding · WC: Working Capital

See the complete picture

The full 5D Framework: Business Quality · Peer Comparison · Valuation · Analyst Sentiment · Smart Money

Explore ARWR on stockoscope.com→

Generated September 20, 2026

For educational purposes only. Not financial advice. Data may be delayed or incomplete.

136 sector peers (United States · Mid Cap · Healthcare)

Relative Quality

ARWR Relative Quality Score

Ranked against 136 sector peers in United States · Mid Cap · Healthcare

Relative Quality

2.4/5

Weak

vs 136 sector peers

Peer Rankings (9 of 10 available)

Relative Quality Score of 2.39/5 (Weak) based on percentile rankings against 136 sector peers in United States · Mid Cap · Healthcare. Each pillar shows a 1-5 score plus the cohort percentile (e.g. 95p = top 5%); higher percentiles indicate stronger relative performance.Last updated September 20, 2026.

Top-Line and Profit Growth

How does the company's growth rate compare to peers?

Revenue Growth

52nd percentile, Adequate

Value: 16.85%
Percentile: 52%
Score: 3/5

PoorWeakAdequateStrongExceptional

Analysis

ARWR has a ttm revenue growth of 16.85% and ranks at the 52nd percentile vs United States · Healthcare sector peers. Adequate financial performance.

Margin Efficiency

Does the company maintain better profit margins than peers?

No data for Gross Margin is available for ARWR, so peer comparison is hidden for this metric. Try another metric.

Operational Efficiency

Is the company more operationally efficient than competitors?

Asset Turnover

31st percentile, Weak

Value: 0.32
Percentile: 31%
Score: 2/5

PoorWeakAdequateStrongExceptional

Analysis

ARWR has a ttm asset turnover of 0.32 and ranks at the 31st percentile vs United States · Healthcare sector peers. Below average financial performance.

Returns Overview

Does the company generate better returns on capital than peers?

ROA

28th percentile, Weak

Value: -15.15%
Percentile: 28%
Score: 2/5

PoorWeakAdequateStrongExceptional

Analysis

ARWR has a ttm roa of -15.15% and ranks at the 28th percentile vs United States · Healthcare sector peers. Below average financial performance.

Cash Flow Quality

How does the company's cash generation compare to peers?

Operating Cash Flow Growth

1st percentile, Poor

Value: -370.34%
Percentile: 1%
Score: 1/5

PoorWeakAdequateStrongExceptional

Analysis

ARWR has a ttm operating cash flow growth of -370.34% and ranks at the 1st percentile vs United States · Healthcare sector peers. Poor financial performance.

Liquidity and Working Capital

Does the company maintain better liquidity positions than competitors?

Cash Ratio

7th percentile, Poor

Value: 0.19
Percentile: 7%
Score: 1/5

PoorWeakAdequateStrongExceptional

Analysis

ARWR has a ttm cash ratio of 0.19 and ranks at the 7th percentile vs United States · Healthcare sector peers. Poor financial performance.

Leverage and Coverage

Is the company's debt burden more manageable than peers?

Debt to Capital

16th percentile, Poor

Value: 0.65
Percentile: 16%
Score: 1/5

PoorWeakAdequateStrongExceptional

Analysis

ARWR has a ttm debt-to-capital of 0.65 and ranks at the 16th percentile vs United States · Healthcare sector peers. Poor financial performance.

Valuation Multiples

Is the company's stock valuation attractive relative to peers?

P / E Ratio

Insufficient peer data

Value: -29.68
Percentile: n/a
Score: n/a

PoorWeakAdequateStrongExceptional

Analysis

Not enough peer data to rank ARWR for ttm p/e ratio in this cohort.

Dividend and Shareholder Yield

Does the company deliver superior income to shareholders compared to peers?

No data for Dividend Yield is available for ARWR, so peer comparison is hidden for this metric. Try another metric.

Peer companies

The 136 companies ARWR is compared against across its sector and industry cohorts.

Arrowhead Pharmaceuticals, Inc.· ARWR

Peer Comparison

Top-Line and Profit Growth

Per-Share Fundamentals

Margin Efficiency

Operational Efficiency

Returns Overview

Cash Flow Quality

Liquidity and Working Capital

Leverage and Coverage

Valuation Multiples

Dividend and Shareholder Yield

Peer companies

Search stocks

Peer Comparison

Top-Line and Profit Growth

Per-Share Fundamentals

Margin Efficiency

Operational Efficiency

Returns Overview

Cash Flow Quality

Liquidity and Working Capital

Leverage and Coverage

Valuation Multiples

Dividend and Shareholder Yield

Peer companies